MORPHOLINE AND TETRAHYDROPYRAN DRIVATIVES AND THEIR USE AS CATHEPSIN INHIBITORS

Details for Australian Patent Application No. 2003245668 (hide)

Owner AVENTIS PHARMACEUTICALS INC.

Inventors TIMM, Andreas, P.; HALLEY, Frank; LAI, Justine; LINK, John; LI, Jiayao; GRAUPE, Michael; PALMER, James, T.; PATTERSON, John, W.; PICKETT, Stephen, D.; ALDOUS, David, J.; THURAIRATNAM, Sukanthini

Pub. Number AU-A-2003245668

PCT Number PCT/US03/19960

PCT Pub. Number WO2004/002491

Priority 10/183,128 26.06.02 US

Filing date 25 June 2003

Wipo publication date 19 January 2004

International Classifications

A61K 031/5375 - 1,4-Oxazines, e.g. morpholine

C07D 295/185 Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms

A61K 031/5377

A61K 031/4245 - Oxadiazoles

C07D 271/06 Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms

C07D 263/56 Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings

C07D 413/12 Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms

C07D 498/04 Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms

C07D 213/40 Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members

Event Publications

25 September 2003 Complete Application Filed

  Priority application(s): 10/183,128 26.06.02 US

4 March 2004 Application Open to Public Inspection

  Published as AU-A-2003245668

17 March 2005 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(f)/See Reg. 8.3(3). Examination has not yet been requested or directed for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

18 August 2005 Corrigenda

  Applications OPI - Name Index Under the name AVENTIS PHARMACEUTICALS INC., Application No. 2003245668, under INID (71) correct the name to read AVENTIS PHARMACEUTICALS INC.; AXYS PHARMACEUTICALS, INC.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003245669-CERTAIN AROMATIC MONOCYCLES AS KINASE MODULATORS

2003245667-SYSTEMS AND METHODS FOR GENERATING HIGH VOLUMES OF FOAM